Schaffhausen, Switzerland – Occlutech, a leading innovator of implants to treat structural heart disease, today announced that it has obtained European CE Mark approval for its Perimembranous Ventricular Septal Defect (PmVSD) Occluder. The device is a specifically designed implant indicated for the minimally invasive closure of perimembranous ventricular septal defects…
